Kazumichi Abe

2.2k total citations
122 papers, 1.4k citations indexed

About

Kazumichi Abe is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Kazumichi Abe has authored 122 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Hepatology, 69 papers in Epidemiology and 31 papers in Surgery. Recurrent topics in Kazumichi Abe's work include Liver Disease Diagnosis and Treatment (62 papers), Liver Diseases and Immunity (52 papers) and Liver Disease and Transplantation (16 papers). Kazumichi Abe is often cited by papers focused on Liver Disease Diagnosis and Treatment (62 papers), Liver Diseases and Immunity (52 papers) and Liver Disease and Transplantation (16 papers). Kazumichi Abe collaborates with scholars based in Japan, United States and Israel. Kazumichi Abe's co-authors include Hiromasa Ohira, Atsushi Takahashi, Manabu Hayashi, Ken Okai, Masashi Fujita, Yukiko Kanno, Hiromichi Imaizumi, Junko Yokokawa, Hironobu Saito and Hiroshi Watanabe and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Scientific Reports.

In The Last Decade

Kazumichi Abe

111 papers receiving 1.4k citations

Peers

Kazumichi Abe
Eray Yagmur Germany
Naota Taura Japan
Konstantinos Thomopoulos Greece
Neşe İmeryüz Türkiye
Peter Ferenci Austria
Sait Bağcı Türkiye
David Díaz Spain
Ruth Ladurner Germany
Mustafa Gülşen Türkiye
Rakesh Kumar Vasishta India
Eray Yagmur Germany
Kazumichi Abe
Citations per year, relative to Kazumichi Abe Kazumichi Abe (= 1×) peers Eray Yagmur

Countries citing papers authored by Kazumichi Abe

Since Specialization
Citations

This map shows the geographic impact of Kazumichi Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazumichi Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazumichi Abe more than expected).

Fields of papers citing papers by Kazumichi Abe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazumichi Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazumichi Abe. The network helps show where Kazumichi Abe may publish in the future.

Co-authorship network of co-authors of Kazumichi Abe

This figure shows the co-authorship network connecting the top 25 collaborators of Kazumichi Abe. A scholar is included among the top collaborators of Kazumichi Abe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazumichi Abe. Kazumichi Abe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Takeuchi, Akihito, Masanori Abe, Sachiko Furukawa, et al.. (2025). Validation of PBC‐10 in Japanese patients with primary biliary cholangitis. Hepatology Research. 55(7). 986–993.
2.
3.
Ito, Takanori, Yasuto Takeuchi, Kazuyuki Mizuno, et al.. (2024). Diagnostic guide for immune checkpoint inhibitor‐induced liver injury. Hepatology Research. 54(8). 719–726. 5 indexed citations
4.
Abe, Kazumichi, et al.. (2024). Long-term outcomes in patients with primary biliary cholangitis complicated with CREST syndrome. Scientific Reports. 14(1). 14124–14124. 1 indexed citations
5.
Takahashi, Atsushi, Hiromasa Ohira, Kazumichi Abe, et al.. (2022). Risk factors for relapse of autoimmune hepatitis in Japan: A nationwide survey. Hepatology Research. 52(7). 597–602. 2 indexed citations
6.
Fujita, Masashi, Kazumichi Abe, Hidekatsu Kuroda, et al.. (2022). Influence of skeletal muscle volume loss during lenvatinib treatment on prognosis in unresectable hepatocellular carcinoma: a multicenter study in Tohoku, Japan. Scientific Reports. 12(1). 6479–6479. 10 indexed citations
7.
Hayashi, Manabu, Kazumichi Abe, Masashi Fujita, et al.. (2022). Circulating complement factor H levels are associated with disease severity and relapse in autoimmune hepatitis. JHEP Reports. 4(7). 100497–100497. 5 indexed citations
8.
Hayashi, Manabu, Masashi Fujita, Jun Nakamura, et al.. (2020). Sigmoid Colon Varices due to Massive Thrombosis of a Noncirrhotic Extrahepatic Portosystemic Shunt. Internal Medicine. 59(21). 2705–2710. 2 indexed citations
9.
Takahashi, Atsushi, Yuichiro Kondo, Masashi Fujita, et al.. (2020). Effects of sleep quality on non-alcoholic fatty liver disease: a cross-sectional survey. BMJ Open. 10(10). e039947–e039947. 17 indexed citations
10.
Fujita, Masashi, Kazumichi Abe, Manabu Hayashi, Atsushi Takahashi, & Hiromasa Ohira. (2020). Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis. Medicine. 99(28). e21061–e21061. 5 indexed citations
11.
Katakura, Kyoko, et al.. (2020). Upregulation of complement C1q reflects mucosal regeneration in a mouse model of colitis. Medical Molecular Morphology. 54(2). 87–94. 4 indexed citations
12.
Takahashi, Atsushi, Hiromichi Imaizumi, Manabu Hayashi, et al.. (2017). Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease. PubMed. 1(1). E2–E7. 14 indexed citations
13.
14.
Saito, Hironobu, Atsushi Takahashi, Kazumichi Abe, et al.. (2011). Two cases of primary biliary cirrhosis associated with systemic lupus erythematosus. Kanzo. 52(3). 169–175. 3 indexed citations
15.
Ohira, Hiromasa, Kazumichi Abe, & Atsushi Takahashi. (2011). Involvement of the liver in rheumatic diseases. Clinical Journal of Gastroenterology. 5(1). 9–14. 5 indexed citations
16.
Abe, Kazumichi, Junko Yokokawa, Kyoko Monoe, et al.. (2009). Re-analysis of patients with autoimmune hepatitis using simplified diagnostic criteria. Kanzo. 50(11). 618–625. 2 indexed citations
17.
Takahashi, Atsushi, Hironobu Saito, Yukiko Kanno, et al.. (2008). Case of clear-cell hepatocellular carcinoma that developed in the normal liver of a middle-aged woman. World Journal of Gastroenterology. 14(1). 129–129. 20 indexed citations
18.
Takahashi, Atsushi, Yukiko Kanno, Yuta Takahashi, et al.. (2008). Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: A case report. World Journal of Gastroenterology. 14(35). 5474–5474. 25 indexed citations
19.
Abe, Kazumichi, Kim Nguyen, Sean Fine, et al.. (2007). Conventional dendritic cells regulate the outcome of colonic inflammation independently of T cells. Proceedings of the National Academy of Sciences. 104(43). 17022–17027. 108 indexed citations
20.
Ohira, Hiromasa, et al.. (2003). . Kanzo. 44(8). 401–406.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eray Yagmur Breakdown of academic impact, for papers by Naota Taura Breakdown of academic impact, for papers by Konstantinos Thomopoulos Breakdown of academic impact, for papers by Neşe İmeryüz Breakdown of academic impact, for papers by Peter Ferenci Breakdown of academic impact, for papers by Sait Bağcı Breakdown of academic impact, for papers by David Díaz Breakdown of academic impact, for papers by Ruth Ladurner Breakdown of academic impact, for papers by Mustafa Gülşen Breakdown of academic impact, for papers by Rakesh Kumar Vasishta
Rankless by CCL
2026